Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naïve Chronic HBV-Infected Patients

METHODS: A total of 111 patients in total from different disease phases were recruited, including 21 in immune-tolerant (IT) phase, 49 in immune-clearance (IC) phases, 29 in immune-control or low replicative (LR) phase, and 12 in reactivation phases. Serum HBV RNA, anti-HBc, HBcrAg, and intrahepatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Hao, Li, Le, Zheng, Wei V., Zou, Jun, Yu, Guangxin, Si, Lanlan, Ge, Feilin, Zhou, Tao, Ji, Dong, Chen, Xiangmei, Xu, Dongping, Cheng, Guanxun, Liu, Yan, Chen, Junhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303147/
https://www.ncbi.nlm.nih.gov/pubmed/35872701
http://dx.doi.org/10.1155/2022/4133283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303147/
https://www.ncbi.nlm.nih.gov/pubmed/35872701
http://dx.doi.org/10.1155/2022/4133283

Ejemplares similares